BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17152260)

  • 21. Vaccinating adolescents and young women against cancer of the cervix.
    Hilgers RD; Wyatt SW
    J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465
    [No Abstract]   [Full Text] [Related]  

  • 22. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M
    Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccination against human papilloma virus. Has cervical cancer been beaten?].
    Kimmig R
    MMW Fortschr Med; 2007 Mar; 149(12):28-9. PubMed ID: 17674886
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 26. [HPV-infection].
    Schmidt-Petruschkat S
    MMW Fortschr Med; 2007 Mar; 149(12):29-31. PubMed ID: 17674887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 29. Writing for CON position: Should the HPV vaccine be mandatory for early adolescent girls?
    Anderson TL
    MCN Am J Matern Child Nurs; 2007; 32(4):209. PubMed ID: 17667282
    [No Abstract]   [Full Text] [Related]  

  • 30. From human papillomavirus to cervical cancer.
    Hang Lee S
    Obstet Gynecol; 2010 Nov; 116(5):1221; author reply 221-2. PubMed ID: 20966723
    [No Abstract]   [Full Text] [Related]  

  • 31. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 32. Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.
    Zubor P; Danko J; Kajo K; Szunyogh N
    J Clin Oncol; 2007 Dec; 25(34):5534-7. PubMed ID: 18048836
    [No Abstract]   [Full Text] [Related]  

  • 33. Human papillomavirus, vaccines and women's health: questions and cautions.
    Lippman A; Melnychuk R; Shimmin C; Boscoe M
    CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
    [No Abstract]   [Full Text] [Related]  

  • 34. HPV vaccination: should it be mandatory for entry into public school?
    Gray JR
    Nurs Womens Health; 2007 Apr; 11(2):133-8. PubMed ID: 17883794
    [No Abstract]   [Full Text] [Related]  

  • 35. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quadrivalent human papillomavirus vaccine.
    Wheat A
    Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317
    [No Abstract]   [Full Text] [Related]  

  • 37. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
    Kjaer SK
    Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
    [No Abstract]   [Full Text] [Related]  

  • 38. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
    Goldie SJ; Kim JJ; Kobus K; Goldhaber-Fiebert JD; Salomon J; O'shea MK; Xavier Bosch F; de Sanjosé S; Franco EL
    Vaccine; 2007 Aug; 25(33):6257-70. PubMed ID: 17606315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three provinces to study 2-dose HPV vaccine.
    Eggertson L
    CMAJ; 2007 Aug; 177(5):444-5. PubMed ID: 17724315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.